Peter Kalev

1.7k total citations
15 papers, 708 citations indexed

About

Peter Kalev is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Peter Kalev has authored 15 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Cell Biology. Recurrent topics in Peter Kalev's work include DNA Repair Mechanisms (7 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (3 papers). Peter Kalev is often cited by papers focused on DNA Repair Mechanisms (7 papers), Epigenetics and DNA Methylation (4 papers) and Protein Degradation and Inhibitors (3 papers). Peter Kalev collaborates with scholars based in United States, Belgium and Bulgaria. Peter Kalev's co-authors include Anna Sablina, Iria Vázquez, Dipanjan Chowdhury, Michal Šimíček, Sandra Nuyts, Layka Abbasi Asbagh, Evert J. Van Limbergen, Esther Hauben, Rüveyda Dok and Sebastian Munck and has published in prestigious journals such as Molecular Cell, Nature Cell Biology and Cancer Cell.

In The Last Decade

Peter Kalev

15 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Kalev United States	10	578	272	99	97	82	15	708
Abbey L. Wentzel United States	9	335 0.6×	344 1.3×	95 1.0×	31 0.3×	84 1.0×	10	568
Xun‐Xun Wan China	9	331 0.6×	149 0.5×	165 1.7×	51 0.5×	50 0.6×	9	458
Seiji Tachiiri Japan	10	547 0.9×	224 0.8×	154 1.6×	41 0.4×	49 0.6×	13	736
Yiu Huen Tsang United States	11	558 1.0×	119 0.4×	240 2.4×	52 0.5×	91 1.1×	13	675
Luis A. Martinez United States	10	601 1.0×	275 1.0×	218 2.2×	40 0.4×	66 0.8×	13	755
J B Little United States	14	336 0.6×	272 1.0×	124 1.3×	38 0.4×	131 1.6×	22	620
Karijn Floor Netherlands	10	400 0.7×	244 0.9×	100 1.0×	37 0.4×	179 2.2×	12	588
Guido Hennig Germany	9	333 0.6×	187 0.7×	137 1.4×	42 0.4×	44 0.5×	10	504
Andrea Milić Canada	9	275 0.5×	221 0.8×	71 0.7×	43 0.4×	139 1.7×	10	557
Maria Leao United Kingdom	7	239 0.4×	197 0.7×	97 1.0×	23 0.2×	24 0.3×	7	456

Countries citing papers authored by Peter Kalev

Since Specialization

Citations

This map shows the geographic impact of Peter Kalev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kalev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kalev more than expected).

Fields of papers citing papers by Peter Kalev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kalev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kalev. The network helps show where Peter Kalev may publish in the future.

Co-authorship network of co-authors of Peter Kalev

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kalev. A scholar is included among the top collaborators of Peter Kalev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kalev. Peter Kalev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kalev, Peter, Nathan Qi, Maureen Kachman, et al.. (2023). Abstract 1095: Exploiting altered methionine metabolism to overcome treatment resistance in glioblastoma. Cancer Research. 83(7_Supplement). 1095–1095. 1 indexed citations

Hyer, Marc L., Peter Kalev, Mark P. Fletcher, et al.. (2020). Abstract 3090: The MAT2A inhibitor, AG-270, combines with both taxanes and gemcitabine to yield enhanced anti-tumor activity in patient-derived xenograft models. Cancer Research. 80(16_Supplement). 3090–3090. 3 indexed citations

Marjon, Katya, Peter Kalev, & Kevin M. Marks. (2020). Cancer Dependencies: PRMT5 and MAT2A in MTAP/p16-Deleted Cancers. 5(1). 371–390. 17 indexed citations

Marjon, Katya, Peter Kalev, Marc L. Hyer, et al.. (2019). Abstract 2714: Targeting MAT2A in CDKN2A/MTAP-deleted cancers. Cancer Research. 79(13_Supplement). 2714–2714. 1 indexed citations

Iniguez, Amanda Balboni, Björn Stolte, Amy Saur Conway, et al.. (2018). EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. Cancer Cell. 33(2). 202–216.e6. 115 indexed citations

Stolte, Björn, Peter Kalev, Nicholas Kwiatkowski, et al.. (2016). Abstract 2441: CDK12/13 inhibition cooperates with the Ewing sarcoma oncoprotein EWS/FLI to attenuate homologous recombination repair in Ewing sarcoma cells. Cancer Research. 76(14_Supplement). 2441–2441. 1 indexed citations

Zheng, Xiao-Feng, Peter Kalev, & Dipanjan Chowdhury. (2015). Emerging role of protein phosphatases changes the landscape of phospho-signaling in DNA damage response. DNA repair. 32. 58–65. 16 indexed citations

Dok, Rüveyda, Peter Kalev, Evert J. Van Limbergen, et al.. (2014). p16INK4a Impairs Homologous Recombination–Mediated DNA Repair in Human Papillomavirus–Positive Head and Neck Tumors. Cancer Research. 74(6). 1739–1751. 99 indexed citations

Lee, Dong-Hyun, Sanket S. Acharya, Mijung Kwon, et al.. (2014). Dephosphorylation Enables the Recruitment of 53BP1 to Double-Strand DNA Breaks. Molecular Cell. 54(3). 512–525. 102 indexed citations

10.

Šimíček, Michal, Sam Lievens, Mathias Laga, et al.. (2013). The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response. Nature Cell Biology. 15(10). 1220–1230. 77 indexed citations

11.

Kalev, Peter, Michal Šimíček, Iria Vázquez, et al.. (2012). Loss of PPP2R2A Inhibits Homologous Recombination DNA Repair and Predicts Tumor Sensitivity to PARP Inhibition. Cancer Research. 72(24). 6414–6424. 103 indexed citations

12.

Vyas, Rajesh, Ramesh Kumar, Frederic F. Clermont, et al.. (2012). RNF4 is required for DNA double-strand break repair in vivo. Cell Death and Differentiation. 20(3). 490–502. 96 indexed citations

13.

Kalev, Peter & Anna Sablina. (2011). Protein Phosphatase 2A as a Potential Target for Anticancer Therapy. Anti-Cancer Agents in Medicinal Chemistry. 11(1). 38–46. 53 indexed citations

14.

Mladenov, Emil, Peter Kalev, & Boyka Anachkova. (2009). The Complexity of Double-Strand Break Ends is a Factor in the Repair Pathway Choice. Radiation Research. 171(4). 397–404. 22 indexed citations

15.

Mladenov, Emil, Peter Kalev, & Boyka Anachkova. (2008). Nuclear matrix binding site in the Rad51 recombinase. Journal of Cellular Physiology. 219(1). 202–208. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact